These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36966561)
1. Differential association between apolipoprotein B and LDL cholesterol and cerebral atherosclerosis according to pre-stroke statin use. Baik M; Nam HS; Heo JH; Lee HS; Kim YD Atherosclerosis; 2023 Apr; 371():14-20. PubMed ID: 36966561 [TBL] [Abstract][Full Text] [Related]
2. Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis. Park JH; Hong KS; Lee J; Kim YJ; Song P Eur J Neurol; 2013 Apr; 20(4):671-80. PubMed ID: 23121297 [TBL] [Abstract][Full Text] [Related]
3. High levels of apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis. Park JH; Hong KS; Lee EJ; Lee J; Kim DE Stroke; 2011 Nov; 42(11):3040-6. PubMed ID: 21868729 [TBL] [Abstract][Full Text] [Related]
4. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Yang WS; Li R; Shen YQ; Wang XC; Liu QJ; Wang HY; Li Q; Yao GE; Xie P Lipids Health Dis; 2020 Jul; 19(1):160. PubMed ID: 32622367 [TBL] [Abstract][Full Text] [Related]
5. Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study. Yao T; Lu W; Ke J; Zhang H; Zhao X; Song B; Liu T; Ke Q; Liu C Front Endocrinol (Lausanne); 2022; 13():865863. PubMed ID: 35573992 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B/AI ratio as an independent risk factor for intracranial atherosclerotic stenosis. Sun Y; Hou XH; Wang DD; Ma YH; Tan CC; Sun FR; Cui M; Dong Q; Tan L; Yu JT Aging (Albany NY); 2019 Sep; 11(17):6851-6862. PubMed ID: 31479420 [TBL] [Abstract][Full Text] [Related]
7. PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis. Wu L; Zhang B; Li C; Zhuang Z; Liu K; Chen H; Zhu S; Zhu J; Dai Z; Huang H; Jiang Y J Neurol Neurosurg Psychiatry; 2024 May; 95(6):529-535. PubMed ID: 38212060 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of apolipoprotein E and risk of intracranial artery stenosis in acute ischemic stroke patients. Kim YJ; Lee SM; Cho HJ; Do HJ; Hong CH; Shin MJ; Kim YS Ann Nutr Metab; 2013; 62(1):26-31. PubMed ID: 23208293 [TBL] [Abstract][Full Text] [Related]
9. Current smoking is associated with extracranial carotid atherosclerotic stenosis but not with intracranial large artery disease. Ji R; Pan Y; Yan H; Zhang R; Liu G; Wang P; Wang Y; Li H; Zhao X; Wang Y; BMC Neurol; 2017 Jun; 17(1):120. PubMed ID: 28651523 [TBL] [Abstract][Full Text] [Related]
10. The Impact of Cerebral Atherosclerosis According to Location on Prognosis after Coronary Artery Bypass Grafting. Lee EJ; Chung CH; Choi KH; Lee JW; Choo SJ; Jung SH; Kang DW; Kim JS; Kwon SU Cerebrovasc Dis; 2018; 46(5-6):200-209. PubMed ID: 30408800 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG J Am Coll Cardiol; 2021 Mar; 77(11):1439-1450. PubMed ID: 33736827 [TBL] [Abstract][Full Text] [Related]
12. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010. Wong ND; Chuang J; Zhao Y; Rosenblit PD J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670 [TBL] [Abstract][Full Text] [Related]
13. PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging. Huang YC; Chang CH; Tsai YH; Weng HH; Lin LC; Lee JD BMJ Open; 2022 Apr; 12(4):e060068. PubMed ID: 35487727 [TBL] [Abstract][Full Text] [Related]
14. Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: a High-Resolution Magnetic Resonance Imaging study (STAMINA-MRI Study). Chung JW; Cha J; Lee MJ; Yu IW; Park MS; Seo WK; Kim ST; Bang OY J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):204-211. PubMed ID: 31371644 [TBL] [Abstract][Full Text] [Related]
15. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571 [TBL] [Abstract][Full Text] [Related]
16. Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke. Suo Y; Jing J; Pan Y; Chen W; Zhou H; Li H; Pu Y; Liu L; Zhao X; Wang Y; Meng X; Wang Y Stroke Vasc Neurol; 2021 Mar; 6(1):33-40. PubMed ID: 32792459 [TBL] [Abstract][Full Text] [Related]
17. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients. Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989 [TBL] [Abstract][Full Text] [Related]
18. 2017 Taiwan lipid guidelines for high risk patients. Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI; J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176 [TBL] [Abstract][Full Text] [Related]
19. Distribution of cerebral artery stenosis and risk factors in ethnic Zhuang and Han patients with ischemic stroke in Guangxi province. Zhou F; Tang J; Li P; Liao B; Qin C Ann Palliat Med; 2020 Mar; 9(2):256-263. PubMed ID: 32156133 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Robinson JG; Wang S; Jacobson TA Am J Cardiol; 2012 Nov; 110(10):1468-76. PubMed ID: 22906895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]